Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Bipolar Diathesis in Patients with Treatment-Resistant Depression

Woo YS, Bahk WM

  • KMID: 2287394
  • Korean J Psychopharmacol.
  • 2009 Sep;20(5):231-236.
Despite the availability of numerous options for the treatment of depression, treatment-resistant depression remains common. Several patient-related and treatment-related risk factors have been identified as increasing the likelihood of nonresponsiveness...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Study of Serum Brain-Derived Neurotrophic Factor in Acute and Chronic Depression

Lee SY, Chung JW, Lim SW, Kim SY, Kim DK

  • KMID: 2287397
  • Korean J Psychopharmacol.
  • 2009 Sep;20(5):254-261.
OBJECTIVE: The aim of this study was to compare the serum brain-derived neurotrophic factor (BDNF) in acute depression with that in chronic depression. METHODS: Eighty subjects who met criteria for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prescription of Antipsychotic Medications to Treat Delirium in a University Hospital during a 5-Year Period

Kim SJ, Kim SY, Kim SW, Shin IS, Kim JM, Yoon JS

  • KMID: 2287398
  • Korean J Psychopharmacol.
  • 2009 Sep;20(5):262-268.
OBJECTIVE: This study investigated the pattern characterizing the prescription of antipsychotic medications to treat delirium in a new university hospital during a 5-year period. METHODS: Retrospective chart review was conducted...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Study for Switching Strategies from Previous Antipsychotics to Aripiprazole: A One-Year Naturalistic Study

Seo TY, Kang MH, Lee JS, Bae JN, Kim CE

  • KMID: 2287396
  • Korean J Psychopharmacol.
  • 2009 Sep;20(5):245-253.
OBJECTIVE: This study analyzed clinical courses to investigate the effectiveness of strategies switching to aripiprazole. METHODS: Patients confirmed DSM-IV diagnoses of schizophrenia who had been treated with aripiprazoleafter switching from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of the Cytochrome P450 Polymorphism on Clinical Response to Aripiprazole in Patients with Schizophrenia

Kim CW, Park HY, Kim CY, Seok JH, Shin YC, Yang DS, Yoon BH, Yi JS, Hong KS, Kwon JS

  • KMID: 2287395
  • Korean J Psychopharmacol.
  • 2009 Sep;20(5):237-244.
OBJECTIVE: Aripiprazole is an atypical antipsychotic drug metabolized partly by the hepatic cytochrome P450 enzyme, CYP2D6. The aim of this study was to investigate the influence of the CYP2D6 polymorphism...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr